bioAffinity Technologies (BIAF) executive compensation, 2026 proxy

Maria Zannes, President and CEO, was paid $434,983 in 2025, down 9% from $477,155 the year before.

Filed
March 16, 2026
Annual meeting
April 30, 2026
Pay year
2025
Named executives
3
CEO total pay
$434,983-9% vs prior year
CEO pay in equity
22%$97,050 in awards
CEO Target Bonus Percentage
20%Percentage of base salary
CEO Maximum Bonus Payout
30%Percentage of base salary
CFO Base Salary
$300,000Annual base salary
Executive Chairman Base Salary
$120,000Annual base salary

How Zannes was paid

$434,983 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Maria ZannesPresident and CEO$434,983
J. Michael EdwardsChief Financial Officer$368,455
Steven GirgentiExecutive Chairman$261,860

What changed and why

  • $435KCEO total compensation decreased to $434,983 in fiscal 2025 from $477,155 in fiscal 2024.
  • 20%Base salaries for named executive officers were targeted with 20% annual bonus opportunities.
  • Annual bonuses were evaluated based on financing, laboratory sales, Department of Defense collaboration, and SEC filings.
  • A clawback policy was adopted for incentive compensation following accounting restatements.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.